Cerrone Gabriele M: insider trades.
Cerrone Gabriele M reported 7 non-derivative transactions on 7 SEC ownership filings in Q3 2026: 4 open-market purchases ($126K) and 0 sales, across 2 companies.
- Transactions
- 7
- Purchases (P)
- 4
- Sales (S)
- 0
- Companies
- 2
- Name as filed
- CERRONE GABRIELE M
Companies
| Company | Relationship | Transactions |
|---|---|---|
| OKYO Pharma Ltd (OKYO) | Director, TenPercentOwner | 4 |
| Tiziana Life Sciences Ltd (TLSA) | Director, TenPercentOwner | 3 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-21 | Tiziana Life Sciences Ltd | P | 42,357 | $0.99 | 44,814,587 | Form 4/A |
| 2026-07-21 | OKYO Pharma Ltd | P | 22,500 | $1.45 | 10,873,916 | Form 4/A |
| 2026-07-21 | Tiziana Life Sciences Ltd | A | 42,357 | $0.99 | 44,814,587 | Form 4 |
| 2026-07-21 | OKYO Pharma Ltd | A | 22,500 | $1.45 | 10,873,916 | Form 4 |
| 2026-07-20 | OKYO Pharma Ltd | P | 25,000 | $1.4 | 10,851,416 | Form 4/A |
| 2026-07-20 | OKYO Pharma Ltd | A | 25,000 | $1.4 | 10,851,416 | Form 4 |
| 2026-06-12 | Tiziana Life Sciences Ltd | P | 15,000 | $1.11 | 44,772,230 | Form 4/A |
Questions
What stock did Cerrone Gabriele M buy or sell?
Cerrone Gabriele M reported 7 non-derivative transactions on 7 SEC ownership filings in Q3 2026: 4 open-market purchases ($126K) and 0 sales, across 2 companies.
Is Cerrone Gabriele M the same person as other filers with this name?
This page covers SEC CIK 1139306 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/cerrone-gabriele-m-1139306.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.